PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease
{{output}}
Background: Epidemiological evidence links the proprotein convertase subtilisin/kexin 7 (PCSK7) to triglyceride (TG) metabolism. We associated the known PCSK7 gain-of-function non-coding SNP rs236918 with higher levels of plasma ... ...
